# Breakthrough Therapy Designation Development Times Data

Data files for the paper **Kathleen Miller, Aaron Kearsley, Ariel D. Stern, and Jennifer Kao. (2024) FDA Breakthrough Therapy Designation Reduced Late-stage Drug Development Times. _Health Affairs_, 43(7), 1003-1010.** [LINK TO PAPER](https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2023.00837)

## Accessing the research data 
_Last update: June 9, 2024,_ _Author: Jennifer Kao_

To use the clinical trial and publication data from this paper, researchers should download the following files: 

* 1_btd_development_times_data.dta
* 2_codebook.pdf

## Notes
* The file **1_btd_development_times_data.dta** provides the publicly available drug-level data used in this study. This contains the set of drugs that have not been excluded 
from the final study (e.g., contraceptives, contrast agents).

## Contact
Please contact Jennifer Kao (jennifer.kao@anderson.ucla.edu) for any questions regarding the data.

**Please see the paper for more information on the data. If you use these data sets, please CITE this paper as the data source.**

